NCT03389230View on ClinicalTrials.gov

Memory-Enriched T Cells in Treating Patients With Recurrent or Refractory Grade III-IV Glioma

PHASE1Active, not recruitingINTERVENTIONAL
Enrollment

29

Participants

Timeline

Start Date

August 14, 2018

Primary Completion Date

January 12, 2026

Study Completion Date

January 12, 2026

Conditions
GlioblastomaMalignant GliomaRecurrent GliomaRefractory GliomaWHO Grade III Glioma
Interventions
BIOLOGICAL

HER2(EQ)BBζ/CD19t+ T cells

Given via catheter

OTHER

Laboratory Biomarker Analysis

Correlative studies

PROCEDURE

Leukapheresis

Undergo leukapheresis

Trial Locations (1)

91010

City of Hope Medical Center, Duarte

All Listed Sponsors
collaborator

National Cancer Institute (NCI)

NIH

lead

City of Hope Medical Center

OTHER